Fathom Digital Manufacturing Reports Fourth Quarter and Full Year 2021 Preliminary Unaudited Financial Results
Fourth Quarter 2021 Highlights Revenue increased 132.8% to $44.3 million; Pro forma revenue1 increased 18.4%…
Fourth Quarter 2021 Highlights Revenue increased 132.8% to $44.3 million; Pro forma revenue1 increased 18.4%…
GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for…
NEW YORK–(BUSINESS WIRE)–Ares Capital Corporation (“Ares Capital”) (NASDAQ:ARCC) announced today that Penni Roll, Ares Capital’s…
Siemens to invest in existing and new sites in Texas and California that develop electrical…
CASPER, Wyo.–(BUSINESS WIRE)–Cowboy Midstream (Cowboy), a full-service midstream provider, has announced the planned opening of…
VALNEVA Declaration of shares and voting rights February 28, 2022__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6…
Bio-industry intelligence firm releases insider analysis of rapidly growing global Biofertilizer market LAKEWOOD RANCH, Fla.–(BUSINESS…
Designed to Accelerate Collaborative Innovation and Support R&D in Europe WILMINGTON, Mass. & LIMERICK, Ireland–(BUSINESS…
DALLAS–(BUSINESS WIRE)–On February 23, 2022, Holly Energy Partners, L.P. (NYSE: HEP) (the “Partnership”) filed with…
NEW YORK–(BUSINESS WIRE)–#banking—Midwest Bank, a locally-owned community bank, providing loans, mortgages, financial planning and investment…
Encouraging preliminary results from BALLI-01 study (evaluating UCART22) in relapsed/refractory B-cell Acute Lymphoblastic Leukemia presented…
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT…
MISSISSAUGA, Ontario, March 03, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
WALTHAM, Mass., March 03, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology…
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics…
Montrouge, France, March 3, 2022 DBV Technologies Reports Full Year 2021 Financial Results and Recent…
– Approximately $113 Million of U.S. Product Sales in 2021 – – Approximately $13 Million…
-Top-line data readout from TERN-201 (VAP-1 inhibitor) clinical trial in NASH expected in March 2022…
SOUTH SAN FRANCISCO, Calif., March 03, 2022 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…